Evidence map›Paper›PMID 41201677›Full record

ArticleArchives of virology2025

Phenotypic and genetic changes of Crimean-Congo hemorrhagic fever virus during serial passage in susceptible cell lines.

Nóra Deézsi-Magyar, Bereniké Novák, Gyula Zsidei, Norbert Solymosi, Marianna Mezősi-Csaplár, Dániel Déri, Bernadett Pályi, Zoltan Kis

Abstract read
In one paragraph

Article in Archives of virology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Nóra Deézsi-MagyarNational Biosafety Laboratory, National Center for Public Health and Pharmacy, Budapest, Hungary.
Bereniké NovákNational Biosafety Laboratory, National Center for Public Health and Pharmacy, Budapest, Hungary.
Gyula ZsideiNational Biosafety Laboratory, National Center for Public Health and Pharmacy, Budapest, Hungary.
Norbert SolymosiUniversity of Veterinary Medicine Budapest, Budapest, Hungary.
Marianna Mezősi-CsaplárNational Biosafety Laboratory, National Center for Public Health and Pharmacy, Budapest, Hungary.
Dániel DériNational Biosafety Laboratory, National Center for Public Health and Pharmacy, Budapest, Hungary.
Bernadett Pályi *National Biosafety Laboratory, National Center for Public Health and Pharmacy, Budapest, Hungary.
Zoltan Kis *National Biosafety Laboratory, National Center for Public Health and Pharmacy, Budapest, Hungary. kis.zoltan@semmelweis.hu.ORCID http://orcid.org/0000-0002-5893-8208

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background Single-stranded RNA viruses such as the Crimean-Congo hemorrhagic fever virus (CCHFV) exhibit a high degree of genetic diversity that can result in the emergence of new viral quasispecies. The aim of this study was to examine the kinetics of CCHFV replication and to identify genetic variations resulting from serial passage in susceptible cell lines that could potentially affect the infectivity and fitness of laboratory virus strains. As efficacy studies of candidate therapeutics and vaccines rely on well-characterized virus stocks, mutations emerging due to virus propagation might result in inaccurate test results. Methods Viral growth kinetics were examined in four cell lines (Vero E6, Vero, SW13, and BHK-21), using different multiplicity-of-infection values. After 10 rounds of serial passaging and cross-passaging, whole-genome sequencing and bioinformatic analysis were performed to map growth-adaptive signature mutations. Results All four cell lines were found to be susceptible to CCHFV infection, and permissivity increased during serial passaging in Vero and BHK-21 cells. Mutations emerged in a cell-line-specific manner, and the particular cell line used for virus propagation had a significant effect on the mutation frequency, especially in the L segment. Conclusions By mapping mutations that occurred during serial passage, we were able to observe viral evolution in a controlled laboratory setting, as well as the accompanying phenotypic changes. Our results provide information about how CCHFV adapts to commonly used cell lines that might be applied for the development of diagnostic tests, antiviral drugs, and vaccines.

Indexed as

Hemorrhagic Fever Virus, Crimean-CongoAnimalsCell LineChlorocebus aethiopsCricetinaeGenetic VariationGenome, ViralHemorrhagic Fever, CrimeanMutationPhenotypeSerial PassageVero CellsVirus ReplicationAdaptationCrimean-Congo hemorrhagic fever virusGenetic changesGrowth-induced mutationsIn vitro testingSerial passagingWhole-genome sequencing

Identifiers

PMID41201677
PMCPMC12594681

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.